Pandect Bioventures is a venture capital firm specializing in funding early-stage biotech and pharma companies. The firm provides investments ranging from seed to Series A and later rounds, supporting startups through various stages of their growth. Pandect Bioventures rigorously assesses opportunities to ensure they align with their strategic focus on innovative healthcare solutions.
Notable portfolio companies include Circle Pharma, which has raised $66 million, and Valitor, with $28 million in funding. The firm boasts top academic and industry advisors who contribute extensive experience in company formation and growth. Additionally, Pandect offers unique value-add services such as access to a state-of-the-art incubator facility and exclusive collaborations with leading research institutions, enhancing the development potential of their portfolio companies.
Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Top Investment Stages
Stage Mix
Concentration shown as share of disclosed investments by stage.
Classification
- Also Known As
- Pandect Bioventures Management, LLC
- NAICS
- 520000Finance and Insurance
- 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
- 523900Other Financial Investment Activities
- 523990All Other Financial Investment Activities
- 523999Miscellaneous Financial Investment Activities
- SIC
- 6700Holding And Other Investment Offices
- 6790Miscellaneous Investing
- 6799Investors, Not Elsewhere Classified
- Industry
- —Financial Services Companies
- —Investment Companies
- —Investment Management Companies
- —Private Equity Firms
- —Venture Capital Firms
Show 6 more industry codes
- NAICS
- 525000Funds, Trusts, and Other Financial Vehicles
- 523910Miscellaneous Intermediation
- 523940Portfolio Management and Investment Advice
- SIC
- 6000Depository Institutions
- 6720Investment Offices
- 6722Management Investment Offices, Open-end
